Biological effects of green tea capsule supplementation in pre-surgery postmenopausal breast cancer patients

Frontiers in Oncology

Volumn 3 DEC, Issue , 2013, Pages

  Yu, Steven S ^a   Spicer, Darcy V ^a   Hawes, Debra ^a   Tseng, Chiu Chen ^a   Yang, Chung S ^b   Pike, Malcolm C ^a,c   Wu, Anna H ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b RUTGERS UNIVERSITY   (United States)

^c MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Chemoprevention; Green tea; Postmenopausal breast cancer

Indexed keywords

CASPASE 3; CD34 ANTIGEN; EPIGALLOCATECHIN GALLATE; ESTROGEN RECEPTOR; GREEN TEA EXTRACT; KI 67 ANTIGEN; PROGESTERONE RECEPTOR;

ADULT; ANGIOGENESIS; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BIOLOGICAL ACTIVITY; BIOPSY; BREAST CANCER; CELL PROLIFERATION; CHEMOPROPHYLAXIS; CLINICAL ARTICLE; CONTROLLED STUDY; DIET SUPPLEMENTATION; DRUG CAPSULE; ELECTROSPRAY MASS SPECTROMETRY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTRADUCTAL CARCINOMA; LIQUID CHROMATOGRAPHY; MIDDLE AGED; PILOT STUDY; POSTMENOPAUSE; PREOPERATIVE EVALUATION; URINALYSIS;

EID: 84892428741     PISSN: None     EISSN: 2234943X     Source Type: Journal    
DOI: 10.3389/fonc.2013.00298     Document Type: Article

References (28)

1. Forouzanfar MH, Foreman KJ, Delossantos AM, Lozano R, Lopez AD, Murray CJ, et al. Breast and cervical cancer in 187 countries between 1980 and 2010: a systematic analysis. Lancet (2011) 378(9801):1461-84. doi: 10.1016/S0140-6736(11)61351-2.
2. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin (2011) 61(2):69-90. doi:10.3322/caac.20107.
3. Wu AH, Yu MC, Tseng CC, Pike MC. Body size, hormone therapy and risk of breast cancer in Asian-American women. Int J Cancer (2007) 120(4):844-52. doi:10.1002/ijc.22387.
4. Wu AH, Butler LM. Green tea and breast cancer. Mol Nutr Food Res (2011) 55(6):921-30. doi:10.1002/mnfr.201100006.
5. Nakachi K, Suemasu K, Suga K, Takeo T, Imai K, Higashi Y. Influence of drinking green tea on breast cancer malignancy among Japanese patients. Jpn J Cancer Res (1998) 89(3):254-61. doi:10.1111/j.1349-7006.1998.tb00556.x.
6. Inoue M, Tajima K, Mizutani M, Iwata H, Iwase T, Miura S, et al. Regular consumption of green tea and the risk of breast cancer recurrence: follow-up study from the Hospital-based Epidemiologic Research Program at Aichi Cancer Center (HERPACC), Japan. Cancer Lett (2001) 167(2):175-82. doi:10.1016/S0304-3835(01)00486-4.
7. Forester SC, Lambert JD. The role of antioxidant versus pro-oxidant effects of green tea polyphenols in cancer prevention. Mol Nutr Food Res (2011) 55(6):844-54. doi:10.1002/mnfr.201000641.
8. Yang CS, Wang X, Lu G, Picinich SC. Cancer prevention by tea: animal studies, molecular mechanisms and human relevance. Nat Rev Cancer (2009) 9(6):429-39. doi:10.1038/nrc2641.
9. Lee MJ, Prabhu S, Meng X, Li C, Yang CS. An improved method for the determination of green and black tea polyphenols in biomatrices by high-performance liquid chromatography with coulometric array detection. Anal Biochem (2000) 279(2):164-9. doi:10.1006/abio.2000.4487.
10. Li C, Lee MJ, Sheng S, Meng X, Prabhu S, Winnik B, et al. Structural identification of two metabolites of catechins and their kinetics in human urine and blood after tea ingestion. Chem Res Toxicol (2000) 13(3):177-84. doi:10.1021/tx9901837.
11. Chung K, Hovanessian-Larsen LJ, Hawes D, Taylor D, Downey S, Spicer DV, et al. Breast epithelial cell proliferation is markedly increased with short-term high levels of endogenous estrogen secondary to controlled ovarian hyperstimulation. Breast Cancer Res Treat (2011) 132(2):653-60. doi:10.1007/s10549-011-1870-y.
12. Hovanessian-Larsen L, Taylor D, Hawes D, Spicer DV, Press MF, Wu AH, et al. Lowering oral contraceptive norethindrone dose increases estrogen and progesterone receptor levels with no reduction in proliferation of breast epithelium: a randomized trial. Contraception (2012) 86(3):238-43. doi:10.1016/j.contraception.2011.12.015.
13. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell (2000) 100:57-70. doi:10.1016/S0092-8674(00)81683-9.
14. Dowsett M, Nielsen TO, A'Hern R, Bartlett J, Coombes RC, Cuzick J, et al. Assessment of Ki67 in breast cancer: recommendations from the International Ki67 in breast cancer working group. J Natl Cancer Inst (2011) 103(22):1656-64. doi:10.1093/jnci/djr393.
15. de Azambuja E, Cardoso F, de Castro G Jr, Colozza M, Mano MS, Durbecq V, et al. Ki-67 as prognostic marker in early breast cancer: a meta-analysis of published studies involving 12,155 patients. Br J Cancer (2007) 96(10):1504-13. doi:10.1038/sj.bjc.6603756.
16. Stuart-Harris R, Caldas C, Pinder SE, Pharoah P. Proliferation markers and survival in early breast cancer: a systematic review and meta-analysis of 85 studies in 32,825 patients. Breast (2008) 17(4):323-34. doi:10.1016/j.breast.2008.02.002.
17. Sheri A, Dowsett M. Developments in Ki67 and other biomarkers for treatment decision making in breast cancer. Ann Oncol (2012) 23(Suppl 10):x219-27. doi:10.1093/annonc/mds307.
18. Stendell-Hollis NR, Thomson CA, Thompson PA, Bea JW, Cussler EC, Hakim IA. Green tea improves metabolic biomarkers, not weight or body composition: a pilot study in overweight breast cancer survivors. J Hum Nutr Diet (2010) 23(6):590-600. doi:10.1111/j.1365-277X.2010.01078.x.
19. Crew KD, Brown P, Greenlee H, Bevers TB, Arun B, Hudis C, et al. Phase IB randomized, double-blinded, placebo-controlled, dose escalation study of polyphenon E in women with hormone receptor-negative breast cancer. Cancer Prev Res (Phila) (2012) 5(9):1144-54. doi:10.1158/1940-6207.CAPR-12-0117.
20. Nguyen MM, Ahmann FR, Nagle RB, Hsu CH, Tangrea JA, Parnes HL, et al. Randomized, double-blind, placebo-controlled trial of polyphenon E in prostate cancer patients before prostatectomy: evaluation of potential chemopreventive activities. Cancer Prev Res (Phila) (2011) 5(2):290-8. doi:10.1158/1940-6207.CAPR-11-0306.
21. Yang CS, Wang H, Li GX, Yang Z, Guan F, Jin H. Cancer prevention by tea: evidence from laboratory studies. Pharmacol Res (2011) 64(2):113-22. doi:10.1016/j.phrs.2011.03.001.
22. Khan N, Mukhtar H. Cancer and metastasis: prevention and treatment by green tea. Cancer Metastasis Rev (2010) 29(3):435-45. doi:10.1007/s10555-010-9236-1.
23. Reuben SC, Gopalan A, Petit DM, Bishayee A. Modulation of angiogenesis by dietary phytoconstituents in the prevention and intervention of breast cancer. Mol Nutr Food Res (2012) 56(1):14-29. doi:10.1002/mnfr.201100619.
24. Leong H, Mathur PS, Greene GL. Inhibition of mammary tumorigenesis in the C3(1)/SV40 mouse model by green tea. Breast Cancer Res Treat (2008) 107(3):359-69. doi:10.1007/s10549-007-9568-x.
25. Sartippour MR, Pietras R, Marquez-Garban DC, Chen HW, Heber D, Henning SM, et al. The combination of green tea and tamoxifen is effective against breast cancer. Carcinogenesis (2006) 27(12):2424-33. doi:10.1093/carcin/bgl066.
26. Chisholm K, Bray BJ, Rosengren RJ. Tamoxifen and epigallocatechin gallate are synergistically cytotoxic to MDA-MB-231 human breast cancer cells. Anticancer Drugs (2004) 15(9):889-97. doi:10.1097/00001813-200410000-00010.
27. Eddy SF, Kane SE, Sonenshein GE. Trastuzumab-resistant HER2-driven breast cancer cells are sensitive to epigallocatechin-3 gallate. Cancer Res (2007) 67(19):9018-23. doi:10.1158/0008-5472.CAN-07-1691.
28. Meeran SM, Patel SN, Li Y, Shukla S, Tollefsbol TO. Bioactive dietary supplements reactivate ER expression in ER-negative breast cancer cells by active chromatin modifications. PLoS One (2012) 7(5):e37748. doi:10.1371/journal.pone.0037748.